SMF Earnings for the Kick off Season July 12, 2010
SMF MASTERS THE AFTER HOURS TRADING WITH HUGE FORWARD
LOOKING PROFITS AND BE ADVISED THAT KEY AREAS ARE…
Continue
Added by ken flagg on July 11, 2010 at 9:56pm —
No Comments
Added by ken flagg on April 30, 2010 at 8:27am —
No Comments
Reports Q1 (Mar) earnings of $0.26 per share, $0.12 better than the Thomson Reuters consensus of $0.14; revenues rose 22.8% year/year to $908.9 mln vs the $849.8 mln consensus. The revenue increase was driven by a 31.6% increase in revenues at Wynn Macau and a 9.3% revenue increase from our Las Vegas operations. Our total cash balances at March 31, 2010 were $1.8 billion. Total debt outstanding at the end of the quarter was $3.3 billion, including… Continue
Added by ken flagg on April 29, 2010 at 10:30pm —
No Comments
Reports Q1 (Mar) earnings
of $0.59 per share, $0.05 better than the Thomson Reuters consensus of
$0.54; revenues rose 25.3% year/year to $493.7 mln vs the $493.1 mln
consensus. Co issues mixed guidance for Q2, sees EPS of $0.62-0.73 vs.
$0.68 Thomson Reuters consensus; sees Q2 revs of $517-525 mln vs.
$516.21 mln Thomson Reuters consensus. Co issues in-line guidance for
FY10, sees EPS of $2.41-2.63 vs. $2.51 Thomson… Continue
Added by ken flagg on April 29, 2010 at 10:13pm —
No Comments
The S&P 500 is up +1.4% to 1208, the Nasdaq is up 1.3% to 2504 and the Dow is up 1.3% to 11184. Action has come on above avg volume (NYSE 552 mln vs avg of 458 mln; NASDAQ 1.40 bln vs avg of 1.08 bln), with advancers outpacing decliners (NYSE advancers/decliners 2172/786, NASDAQ advancers/decliners 1677/926) with new highs outpacing new lows (NYSE new highs/new lows 210/6, and NASDAQ new highs/new lows 141/5).
ETF relative… Continue
Added by ken flagg on April 29, 2010 at 9:53pm —
No Comments
FDA confirms it has approved Dendreon's Provenge (sipuleucel-T), a new therapy for certain men with advanced prostate cancer that uses their own immune system to fight the disease. The effectiveness of Provenge was studied in 512 patients with metastatic hormone treatment refractory prostate cancer in a randomized, double-blind, placebo-controlled, multicenter trial, which showed an increase in overall survival of 4.1 months. The median survival for… Continue
Added by ken flagg on April 29, 2010 at 3:16pm —
No Comments
Added by ken flagg on April 29, 2010 at 10:20am —
No Comments
Kaufman notes last night FSLR reported 1Q10 revenues of $568 mln and EPS of
$2.00. This was significantly above consensus forecasts for revs of $546 mln
and EPS of $1.65. The better-than-anticipated results were driven by strong
demand across all of Europe , better pricing and increased manufacturing
throughput. Given the better-than-expected results in 1Q and the increased
visibility provided by the… Continue
Added by ken flagg on April 29, 2010 at 9:50am —
No Comments
In reaction to strong earnings/guidance: IRBT +22.9%, GMET +16.3% (light volume), BIDU +15.1%, NENG +13.8% (also filed for a $40 mln mixed shelf offering), SFI +10.4%, ILMN +10.3%, AKAM +9.9%, AXTI +8.8%, MOT +8.4%, TLCR +8.0% (light volume), GTI +7.7%, DRAD +7.1%, CSCX +7.1% (also comments on FDA AED recall communication), FSLR +6.9% (also upgraded to Outperform at Robert W. Baird, upgraded to Buy from Hold at Deutsche Bank), TSRA +6.8%, OMX +6.2%… Continue
Added by ken flagg on April 29, 2010 at 9:15am —
No Comments
Reports Q1 (Mar) earnings of $1.09 per share, $0.12 worse than the Thomson Reuters consensus of $1.21; revenues rose 64.6% year/year to $116.2 mln vs the $116.8 mln consensus. Co states, "Regarding the sequential increase in operating expenses from fourth quarter 2009, approximately $6 million of that increase relates to increases in arbitration and litigation expenses, an adjustment to the company's long-term compensation accrual and seasonal… Continue
Added by ken flagg on April 29, 2010 at 7:52am —
No Comments
Reports Q1 (Mar) earnings of $0.22 per share, excluding non-recurring items, $0.03 worse than the Thomson Reuters consensus of $0.25; revenues rose 20.1% year/year to $750.3 mln vs the $847.5 mln consensus. Revenues increased 20% over Q1 2009 on gold sales of 569,100 ounces. Total cash costs for the quarter were $325 per ounce on a by-product basis and $433 per ounce on a co-product basis. The co said that construction of Pueblo Viejo in the Dominican… Continue
Added by ken flagg on April 29, 2010 at 7:50am —
No Comments
BIDU Baidu.com surges over 80 points upon resumption of trading (621.38 +1.27) -Update-
Added by ken flagg on April 29, 2010 at 7:49am —
No Comments
Reports Q1 (Mar) earnings of $0.71 per share, $0.03 worse than the Thomson Reuters consensus of $0.74; revenues were unchanged from the year-ago period at $435.2 mln. Co issues in-line guidance for Q2, sees EPS of $0.80-0.85 vs. $0.85 Thomson Reuters consensus. Co reaffirms guidance for FY10, sees EPS of $3.25-3.55 vs. $3.45 Thomson Reuters consensus. Co says "Looking longer term, our belief that the oil and gas industry will continue to invest in… Continue
Added by ken flagg on April 29, 2010 at 7:44am —
No Comments
Brean Murray initiates the China Internet advertising sector. They expect stellar growth in online advertising this year on the back of a 30%+ expansion in client budgets. They expect market leaders to further separate themselves from the pack and continue to capture a disproportionate amount of spending. The firm initiates Baidu (BIDU) with a Buy and an $800 tgt, Sina (SINA) with a Buy and a $50 tgt and Sohu (SOHU) with a Hold.
Added by ken flagg on April 28, 2010 at 8:36am —
No Comments
Reports Q1 (Mar) earnings of $0.62 per share, excluding non-recurring items, $0.07 better than the Thomson Reuters consensus of $0.55; revenues rose 51.4% year/year to $126.7 mln vs the $123.4 mln consensus. Co issues upside guidance for Q2, sees Q2 revs of $131-135 mln vs. $128.23 mln Thomson Reuters consensus. Strong performance for the quarter was led by the company's broad-based products, which were up 11 percent sequentially. Strength in… Continue
Added by ken flagg on April 28, 2010 at 8:32am —
No Comments
Companies trading higher in after hours in reaction to earnings: RFMD +3.8%, BRCM +2.2%, LIFE +1.2%... Companies trading lower in after hours in reaction to earnings: BWLD -20.5%, AMAG -13.5%, RHI -10.0%, MTW -7.5%, CNXT -7.2%, PMTC -5.3%, FLEX -3.7%, PNRA -3.5%, AMKR -3.0%, PNC -2.2%.
Added by ken flagg on April 28, 2010 at 5:51am —
No Comments
Companies trading higher in after hours in reaction to earnings: RFMD +3.8%, BRCM +2.2%, LIFE +1.2%... Companies trading lower in after hours in reaction to earnings: BWLD -20.5%, AMAG -13.5%, RHI -10.0%, MTW -7.5%, CNXT -7.2%, PMTC -5.3%, FLEX -3.7%, PNRA -3.5%, AMKR -3.0%, PNC -2.2%.
Added by ken flagg on April 28, 2010 at 5:51am —
No Comments
Treasuries were able to maintain most of their gains in the face of at-record sized supply, a somewhat sloppy auction and improved data, as the ongoing drama in Europe was escalated some, specifically regarding Greece and Portugal ...in case someone missed that. The 10-yr was run up to trade off to a 3.674% yield, the mid-curve leading the charge with the 5-yrs and out the curve getting to the best levels in a month. The drop-off in stocks added to the… Continue
Added by ken flagg on April 28, 2010 at 5:50am —
No Comments
Although currently trading lower with the overall market, casual bakery/cafe Panera Bread (PNRA) is only 2 points off all-time highs headed into tonight's earnings release. The co is scheduled to report Q1 results today after the close followed by conference call tomorrow morning at 8:30am ET. Current consensus is Q1 EPS up 43% y/y to $0.82 on revs up 14% y/y to $364.76 mln; Q2 EPS of $0.84 on revs of $375.15 mln; and FY10 EPS up 27% to $3.52 on revs… Continue
Added by ken flagg on April 28, 2010 at 5:46am —
No Comments
The S&P is down 1.6% to 1193, the Nasdaq is down 1.6% to 2484 and the Dow is down 1.3% to 11064. Action has come on above avg volume (NYSE 684 mln vs avg of 449 mln; NASDAQ 1.28 bln vs avg of 1.07 bln), with decliners outpacing advancers (NYSE advancers/decliners 524/2502, NASDAQ advancers/decliners 623/2011).
ETF relative strength:
Sector: Volatility-VXX +8.6%, 20+ yr Treasuries-TLT +1.3%, Gold-GLD +0.8%.
Regional: Yen-FXY… Continue
Added by ken flagg on April 27, 2010 at 3:48pm —
No Comments